Avatrombopag Maleate is a thrombopoietin receptor agonist that stimulates platelet production, used to raise platelet counts ahead of procedures in patients with chronic liver disease and in chronic immune thrombocytopenia. Simson Pharma's Avatrombopag Maleate reference standard and impurities support compendial testing for this haematology therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Avatrombopag Maleate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.